Twist Bioscience Corp. (NASDAQ:TWST) is one of the best emerging technology stocks to buy right now. The company manufactures ...

The company plans to raise money this fall to support the continued development of its head-and-neck cancer testing platform and oral squamous cell carcinoma test.

Born from personal experience and backed by scientific excellence, MYmAb Biologics is leading a quiet revolution in cancer research—anchored in Malaysia, aiming for the world.

Prior dengue infection reshapes innate immunity, boosting vaccine efficacy. Vaccination alone fails to replicate these immune ...

Stem cells and organoids are revolutionising medical advancements. The journey from stem cell research to translational ...

CPT codes for OGM are key components for obtaining reimbursement from third party payers when labs use LDTs based on OGM as alternatives to legacy cytogenetics methods such as karyotyping, ...

PUNE, MAHARASHTRA, INDIA, September 15, 2025 /EINPresswire.com/ -- The global Silicon as a Platform (SaaP) market Size was valued at USD 14.14 billion in 2024 and is projected to ...

In the post-genomic era, long non-coding RNAs (lncRNAs) have emerged as critical regulators in various cancers and hold potential as minimally invasive diagnostic biomarkers. This study aimed to ...

The global cell analyzer market is projected to grow at a CAGR of 8% from 2025 to 2030, driven by the rising prevalence of ...

LONDON, GREATER LONDON, UNITED KINGDOM, September 12, 2025 /EINPresswire.com/ -- Genetic Analysis Market Growth Forecast: What To Expect By 2025? The market size for genetic analysis has seen a swift ...

A new smart pimple patch developed with 3D-printed microarray spikes clears acne in just seven days. Clinically tested, the ...

Acne vulgaris affects over 650 million people worldwide, especially teenagers. About 85% of teens develop acne, and many face ...